CNTA

Centessa Pharmaceuticals plc American Depositary Shares
Data: 2026-01-30
$24.57
Price
-1.25%
Change
$30.58
52W High
$9.6
52W Low

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Quick Stats
Jan 30, 2026

54.6

AI Score

HOLD

0.73

Volume Ratio

Mar 26, 2026

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

CNTA Stock Summary

Last updated Jan 30, 2026

CNTA is currently trading at $24.57, positioned above its 200-day moving average of $19.47, indicating a long-term uptrend. The stock has a 52-week range of $9.6 to $30.58.

Technical Analysis: The 50-day moving average stands at $25.75, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 51.056, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.01, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CNTA at 54.6/100 with a HOLD recommendation.

CNTA (Centessa Pharmaceuticals plc American Depositary Shares) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 51.056
CMF (20) -0.01
ROC (10) 9.688
ADX (14) 24.638
Indicator Value
MACD (12,26,9) 0.066
AROONOSC (14) 28.571
WILLAMS %R (14) -40.156
MFI (14) 74.36
CNTA Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

CNTA Price vs Max Options Open Interest
CNTA Max Change In Options Open Interest

CNTA Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CNTA Daily Out of Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CNTA Daily In the Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CNTA Most Active Options by Volume(near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Centessa Pharmaceuticals plc American Depositary Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

CNTA Moving Averages Analysis

Centessa Pharmaceuticals plc American Depositary Shares has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026

CNTA (Centessa Pharmaceuticals plc American Depositary Shares) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 24.47
20 23.5
30 24.03
50 25.75
100 24.55
200 19.47

CNTA Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 3.6 billion
Earnings/Share ($) -1.89
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -1.341
EPS Estimate Next Year ($) -1.676
WallStreet Target Price ($) 39.6154
Most Recent Quarter